Literature DB >> 15960987

The role of mast cells in migraine pathophysiology.

Theoharis C Theoharides1, Jill Donelan, Kristiana Kandere-Grzybowska, Aphrodite Konstantinidou.   

Abstract

Mast cells are critical players in allergic reactions, but they have also been shown to be important in immunity and recently also in inflammatory diseases, especially asthma. Migraines are episodic, typically unilateral, throbbing headaches that occur more frequently in patients with allergy and asthma implying involvement of meningeal and/or brain mast cells. These mast cells are located perivascularly, in close association with neurons especially in the dura, where they can be activated following trigeminal nerve, as well as cervical or sphenopalatine ganglion stimulation. Neuropeptides such as calcitonin gene-related peptide (CGRP), hemokinin A, neurotensin (NT), pituitary adenylate cyclase activating peptide (PACAP), and substance P (SP) activate mast cells leading to secretion of vasoactive, pro-inflammatory, and neurosensitizing mediators, thereby contributing to migraine pathogenesis. Brain mast cells can also secrete pro-inflammatory and vasodilatory molecules such as interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF), selectively in response to corticotropin-releasing hormone (CRH), a mediator of stress which is known to precipitate or exacerbate migraines. A better understanding of brain mast cell activation in migraines would be useful and could lead to several points of prophylactic intervention.

Entities:  

Mesh:

Year:  2005        PMID: 15960987     DOI: 10.1016/j.brainresrev.2004.11.006

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  73 in total

1.  Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP.

Authors:  Henrik Winther Schytz; Helle Holst; Lars Arendt-Nielsen; Jes Olesen; Messoud Ashina
Journal:  J Headache Pain       Date:  2010-05-09       Impact factor: 7.277

2.  pH-evoked dural afferent signaling is mediated by ASIC3 and is sensitized by mast cell mediators.

Authors:  Jin Yan; Xiaomei Wei; Christina Bischoff; Rebecca M Edelmayer; Gregory Dussor
Journal:  Headache       Date:  2013-06-28       Impact factor: 5.887

3.  Mast cells in the human dura: effects of age and dural bleeding.

Authors:  A Varatharaj; J Mack; J R Davidson; A Gutnikov; W Squier
Journal:  Childs Nerv Syst       Date:  2012-01-22       Impact factor: 1.475

4.  Developmental changes of mast cell populations in the cerebral meninges of the rat.

Authors:  Helen Michaloudi; Christos Batzios; Maria Chiotelli; Georgios C Papadopoulos
Journal:  J Anat       Date:  2007-09-06       Impact factor: 2.610

Review 5.  CGRP as a neuropeptide in migraine: lessons from mice.

Authors:  Andrew F Russo
Journal:  Br J Clin Pharmacol       Date:  2015-07-14       Impact factor: 4.335

Review 6.  CGRP and migraine: could PACAP play a role too?

Authors:  Eric A Kaiser; Andrew F Russo
Journal:  Neuropeptides       Date:  2013-10-23       Impact factor: 3.286

Review 7.  Migraine-associated risks and comorbidity.

Authors:  H C Diener; M Küper; T Kurth
Journal:  J Neurol       Date:  2008-09-30       Impact factor: 4.849

8.  Role of meningeal mast cells in intrathecal morphine-evoked granuloma formation.

Authors:  Tony L Yaksh; Jeffery W Allen; Samantha L Veesart; Kjersti A Horais; Shelle A Malkmus; Miriam Scadeng; Joanne J Steinauer; Steve S Rossi
Journal:  Anesthesiology       Date:  2013-03       Impact factor: 7.892

9.  Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin.

Authors:  Kristiana Kandere-Grzybowska; Duraisamy Kempuraj; Jing Cao; Curtis L Cetrulo; Theoharis C Theoharides
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

10.  Lymphocyte subsets in pediatric migraine.

Authors:  Aron Cseh; Kristof Mark Farkas; Laszlo Derzbach; Katalin Muller; Barna Vasarhelyi; Balazs Szalay; Andras Treszl; Viktor Farkas
Journal:  Neurol Sci       Date:  2012-10-16       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.